Skip to content

The COMRADE study.

Small bowel imaging COmparing MR Enteroclysis and Video CApsule with Double-Balloon Endoscopy; the COMRADE study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23200
Enrollment
80
Registered
2006-09-05
Start date
2006-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This will be a prospective study comparing two imaging techniques. MR enteroclysis will be performed at the department of Radiology of the Medical Centre Alkmaar. The double-balloon enteroscopy and videocapsule will be performed at the department of Gastroenterology of the Medical Centre Alkmaar and the department of Gastroenterology and Hepatology of the Erasmus Medical Centre Rotterdam.

Interventions

1. MRI enteroclysis 2. Double ballon endoscopy 3. Videocapsule

Sponsors

Schering AG, Christiane Pering, M.D. Siemens Nederland, Ronald Prinsze
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of >18 and < 75 years 2. One of the following patient groups: 2.1 Patients with suspected Crohn’s disease 2.2 Patients with Crohn’s disease, in need of visualization of the small bowel because of suspected disease activity. 2.3 Patients with signs of chronic or repeated gastrointestinal bleeding with negative gastroscopy and colonoscopy 3. Patients must be able to give informed consent and the consent must be obtained prior to any study procedures

Exclusion criteria

Exclusion criteria: 1. Patients with suspected intra-abdominal abscess 2. Abdominal surgery in the 6 weeks prior to inclusion 3. Patients with clinical suspicion of high grade small bowel obstruction 4. Pregnancy 5. Breastfeeding 6. Inability to swallow the video capsule 7. Presence of a pacemaker or cardioversion device 8. Patients with a history of contrast media reaction and history of allergy (esp. asthma) 9. Severe concomitant disease with limited life expectancy 10. A psychiatric, addictive, or any disorder that compromises ability to give truly informed consent for participation in this study.

Design outcomes

Primary

MeasureTime frame
diagnostic yield, including location and nature of lesions. The pathologic findings in the small bowel of the different diagnostic methods will be correlated with each other to analyse location and nature of lesions. For patients with known or suspected Crohn’s disease of the small bowel, a comparison will be made for prevalence, location, severity of inflammatory lesions, and complications such as formation of stenotic lesions. For patients with gastrointestinal blood loss, the techniques will be compared for prevalence and location of bleeding foci and characters of the lesion. The findings at the double balloon endoscopy will be used as the gold standard.

Secondary

MeasureTime frame
patients’ appreciation of the different diagnostic methods. This will be analysed by means of a questionnaire. Patients will be asked to repeatedly fill out the same questionnaire, 24 hours before and after each examination and 5 weeks after all the examinations.

Contacts

Public ContactB.M. Wiarda

Medical Center Alkmaar P.O.Box 500

b.m.wiarda@mca.nl+31(0)72 5483419

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)